cupure logo
heres2025topweekoctobernetflixtrumpdealfreeshows

AstraZeneca to upgrade US listing in ‘knock-back for London’

UK’s biggest drugmaker will put its US shares on a par with its London-based stock but says HQ will stay in CambridgeGSK’s Emma Walmsley to be replaced as CEOThe UK’s biggest drugmaker, AstraZeneca, has said it will list its shares directly on the New York Stock Exchange in a decision described as a “knock-back for London”.The FTSE 100 company said its direct listing in New York would replace trading in its American depositary receipts (ADRs) – which give US investors exposure to a non-US company – on the Nasdaq. Continue reading...

Comments

Business News